Arch Venture Fund XII, 10% Owner: Neumora Therapeutics NMRA Buy · Filed 25/10/29

Trade details

Type: Insider buy
Amount: $4,999,977
Shares · price: 1,915,700 sh · $2.61 a share
Held after: 6,046,907 sh
Stock: Neumora Therapeutics NMRA
Person: Arch Venture Fund XII10% Owner
Trade date: 25/10/27
Filed: 25/10/29
Days to filing: 2 days

First buy in 2 years

Since the last buy: 2 years
Last buy: 23/11/14
Insiders buying this week: 18 insiders
Holding change: +46.4%

Neumora Therapeutics trades, last 26 weeks

What else happened in Neumora Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/27~25/11/26

Arch Venture Fund XII's recent trades

Arch Venture Fund XII10% Owner
BuySeaport Therapeutics
Buy
Seaport Therapeutics
SPTX
$19.8M
1,100,000 sh
$19.8M
Filed 05/04
Traded 05/04
Arch Venture Fund XII10% Owner
BuyPrime Medicine
Buy
Prime Medicine
PRME
$10M
3,030,300 sh
$10M
Filed 25/08/01
Traded 25/08/01
Arch Venture Fund XII10% Owner
BuyMetsera
Buy
Metsera
MTSR
$25.8M
1,432,224 sh
$25.8M
Filed 25/02/03
Traded 25/02/03
Arch Venture Fund XII10% Owner
BuyMetsera
Buy
Metsera
MTSR
$14.2M
789,998 sh
$14.2M
Filed 25/02/03
Traded 25/02/03
Arch Venture Fund XII10% Owner
BuyPrime Medicine
Buy
Prime Medicine
PRME
$20M
3,200,000 sh
$20M
Filed 24/02/20
Traded 24/02/15